Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Transient Loss of Ventricular Pacing Capture Caused by Vagal Induced Ventricular Refractoriness: A Novel, Mechanism for Pacemaker Failure in Vaso-Vagal Syncope.

Malik V, Alasady M, Arnolda LF.

J Cardiovasc Electrophysiol. 2016 Mar 11. doi: 10.1111/jce.12970. [Epub ahead of print]

PMID:
26969794
2.

Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia.

Holobotovskyy V, Chong YS, Burchell J, He B, Phillips M, Leader L, Murphy TV, Sandow SL, McKitrick DJ, Charles AK, Tare M, Arnolda LF, Ganss R.

Sci Transl Med. 2015 Jun 3;7(290):290ra88. doi: 10.1126/scitranslmed.aaa5038.

PMID:
26041705
3.

Intrapericardial injections using a novel technique.

Holobotovskyy VV, Arnolda LF, McKitrick DJ.

Wiad Lek. 2014;67(2 Pt 2):154-6.

PMID:
25796813
4.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators.

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
5.

Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling.

Holobotovskyy V, Manzur M, Tare M, Burchell J, Bolitho E, Viola H, Hool LC, Arnolda LF, McKitrick DJ, Ganss R.

Circ Res. 2013 Mar 1;112(5):781-91. doi: 10.1161/CIRCRESAHA.111.300142. Epub 2013 Jan 9.

6.

Systemic arterial inflammation, measured with 18FDG-PET, is common amongst subjects with both recent and prior cerebrovascular disease.

Beer CD, Potter K, Lenzo N, Blacker D, Arnolda LF, Hankey GJ, Puddey IB.

Clin Neurol Neurosurg. 2012 Jul;114(6):613-6. doi: 10.1016/j.clineuro.2011.12.023. Epub 2012 Jan 5.

PMID:
22226631
7.

Changes in oxygen tension affect cardiac mitochondrial respiration rate via changes in the rate of mitochondrial hydrogen peroxide production.

Di Maria CA, Bogoyevitch MA, McKitrick DJ, Arnolda LF, Hool LC, Arthur PG.

J Mol Cell Cardiol. 2009 Jul;47(1):49-56. doi: 10.1016/j.yjmcc.2009.03.010. Epub 2009 Mar 25.

PMID:
19328207
8.

Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial.

Potter K, Lenzo N, Eikelboom JW, Arnolda LF, Beer C, Hankey GJ.

Cerebrovasc Dis. 2009;27(3):259-65. doi: 10.1159/000199463. Epub 2009 Feb 6.

PMID:
19202330
9.

The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.

Potter K, Hankey GJ, Green DJ, Eikelboom J, Jamrozik K, Arnolda LF.

BMC Cardiovasc Disord. 2008 Sep 20;8:24. doi: 10.1186/1471-2261-8-24. Review.

10.

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P.

Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Erratum in: Lancet. 2008 Oct 18;372(9647):1384.

PMID:
18757085
11.

Immunohistochemical assessment of cyclic guanosine monophosphate (cGMP) and soluble guanylate cyclase (sGC) within the rostral ventrolateral medulla.

Powers-Martin K, Barron AM, Auckland CH, McCooke JK, McKitrick DJ, Arnolda LF, Phillips JK.

J Biomed Sci. 2008 Nov;15(6):801-12. doi: 10.1007/s11373-008-9269-4. Epub 2008 Jul 6.

PMID:
18604639
12.

Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.

Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R; FUSION II Investigators.

Circ Heart Fail. 2008 May;1(1):9-16. doi: 10.1161/CIRCHEARTFAILURE.108.767483.

13.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.

14.

Homocysteine or renal impairment: which is the real cardiovascular risk factor?

Potter K, Hankey GJ, Green DJ, Eikelboom JW, Arnolda LF.

Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1158-64. doi: 10.1161/ATVBAHA.108.162743. Epub 2008 Mar 20.

15.

Ultrasound settings significantly alter arterial lumen and wall thickness measurements.

Potter K, Reed CJ, Green DJ, Hankey GJ, Arnolda LF.

Cardiovasc Ultrasound. 2008 Jan 22;6:6. doi: 10.1186/1476-7120-6-6.

16.

Carotid intima-medial thickness measured on multiple ultrasound frames: evaluation of a DICOM-based software system.

Potter K, Green DJ, Reed CJ, Woodman RJ, Watts GF, McQuillan BM, Burke V, Hankey GJ, Arnolda LF.

Cardiovasc Ultrasound. 2007 Sep 24;5:29.

17.

Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease.

Phillips JK, Hopwood D, Loxley RA, Ghatora K, Coombes JD, Tan YS, Harrison JL, McKitrick DJ, Holobotvskyy V, Arnolda LF, Rangan GK.

Kidney Blood Press Res. 2007;30(3):129-44. Epub 2007 Apr 19.

PMID:
17446713
18.

Intrathecal cGMP elicits pressor responses and maintains mean blood pressure during haemorrhage in anaesthetized rats.

Malik V, Holobotovskyy VV, Phillips JK, McKitrick DJ, Arnolda LF.

J Physiol. 2007 Jun 1;581(Pt 2):543-52. Epub 2007 Mar 8.

20.

Effects of training resumption on conduit arterial diameter in elite rowers.

Naylor LH, O'Driscoll G, Fitzsimons M, Arnolda LF, Green DJ.

Med Sci Sports Exerc. 2006 Jan;38(1):86-92.

PMID:
16394958
Items per page

Supplemental Content

Loading ...
Write to the Help Desk